← All Posts
April 2025 De-Extinction Gene Editing Colossal Biosciences

Dire Wolves Return: Colossal's Next Big Leap After the Woolly Mice

Three wolf pups engineered to resemble extinct dire wolves. The biotech is impressive, but the "de-extinction" label deserves scrutiny.

In this article

  1. What Happened
  2. The Biotech
  3. Why "De-Extinction" Is the Wrong Word
  4. My Take

Key takeaways

  • Colossal Biosciences edited 20 genes in gray wolf embryos to produce pups with dire wolf-like traits — larger size, denser fur, and Ice Age features.
  • This is precision gene editing for phenotypic recreation, not resurrection — the full dire wolf genome is unrecoverable from degraded ancient DNA.
  • Editing 20 genes simultaneously with viable offspring and intended phenotypes is a genuine technical achievement.
  • Calling it "de-extinction" oversells what the technology can do and risks confusing public understanding of gene editing.

What Happened

Colossal Biosciences announced the birth of three wolf pups, Romulus, Remus, and Khaleesi, engineered to resemble the extinct dire wolf. The company edited 20 genes in gray wolf embryos using ancient DNA extracted from dire wolf fossils. The resulting pups have larger body size, denser fur, and physical features that echo their Ice Age ancestors, which went extinct over 13,000 years ago.

This comes on the heels of their "woolly mice" project, where they used similar techniques to give mice mammoth-like fur. Colossal is building a track record of using gene editing to recreate extinct traits in living animals, and they're doing it with increasing sophistication.

The Biotech

What Colossal is actually doing is precision gene editing, not resurrection. They can't clone a dire wolf: the DNA is too degraded after 13,000 years. What they can do is sequence fragments of preserved dire wolf DNA, identify the genes responsible for the traits that made dire wolves distinct (size, bone density, coat type), and then edit the corresponding genes in a modern gray wolf embryo.

Editing 20 genes simultaneously is technically hard. Each edit needs to land in the right place without causing off-target effects, and the interactions between those genes aren't fully predictable. That they produced three viable pups with the intended phenotypic changes is a genuine technical achievement.

Why "De-Extinction" Is the Wrong Word

These aren't dire wolves. They're gray wolves with 20 edited genes that make them look like dire wolves. The distinction matters. A true dire wolf had a full genome shaped by tens of thousands of years of evolution (metabolic pathways, immune responses, behavioral tendencies, gut microbiome), most of which we can't reconstruct from fragmentary ancient DNA. What Colossal has created is a phenotypic approximation: an animal that resembles an extinct species without sharing its complete biology.

These aren't dire wolves. They're gray wolves with 20 edited genes that make them look like dire wolves.

Some scientists have pushed back on the "de-extinction" framing for exactly this reason. It's gene editing applied to phenotypic recreation, and calling it de-extinction oversells what the technology can actually do.

Opinion

My Take

The gene editing work here is genuinely impressive. Editing 20 genes in a coordinated way, producing viable animals, and getting the phenotypes you intended. That's a hard problem and Colossal solved it. From a pure biotech perspective, this is meaningful progress.

But I think the "de-extinction" framing is doing real damage to public understanding of what's happening. These are engineered gray wolves with some dire wolf traits. They're not dire wolves. Conflating the two confuses people about what gene editing can and can't do, and it hands easy ammunition to critics who want to dismiss the entire field as hype.

The conservation argument that reviving extinct species could fill ecological niches is worth taking seriously, but only if we're honest about what we're actually reviving. A modified gray wolf living on a preserve isn't restoring an ecosystem. It's proving a technology. Both are valuable, but they're not the same thing.

Related posts

March 2025

The Return of the Woolly Mammoth

Woolly mice, mammoth fur genes, and whether de-extinction is worth pursuing.

May 2025

Gene Fix: Biotech's Quiet Revolution in Human DNA

CRISPR therapies are now editing genes in real patients. What changes, and what doesn't.